These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 1796815

  • 1. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions.
    Ohta Y, Katayama I, Funato T, Yokozeki H, Nishiyama S, Hirano T, Kishimoto T, Nishioka K.
    Arch Dermatol Res; 1991; 283(6):351-6. PubMed ID: 1796815
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-1 and interleukin-6 in psoriasis.
    Prens EP, Benne K, van Damme J, Bakkus M, Brakel K, Benner R, van Joost T.
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):121S-124S. PubMed ID: 2258628
    [Abstract] [Full Text] [Related]

  • 3. In situ expression of interleukin-6 in psoriatic epidermis during treatment.
    Ohta Y, Nishiyama S, Nishioka K.
    J Dermatol; 1994 May; 21(5):301-7. PubMed ID: 8051314
    [Abstract] [Full Text] [Related]

  • 4. Increased mRNA expression of manganese superoxide dismutase in psoriasis skin lesions and in cultured human keratinocytes exposed to IL-1 beta and TNF-alpha.
    Löntz W, Sirsjö A, Liu W, Lindberg M, Rollman O, Törmä H.
    Free Radic Biol Med; 1995 Feb; 18(2):349-55. PubMed ID: 7744320
    [Abstract] [Full Text] [Related]

  • 5. IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine.
    Onderdijk AJ, Baerveldt EM, Kurek D, Kant M, Florencia EF, Debets R, Prens EP.
    J Immunol; 2015 Aug 15; 195(4):1744-52. PubMed ID: 26170379
    [Abstract] [Full Text] [Related]

  • 6. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
    Debets R, Hegmans JP, Croughs P, Troost RJ, Prins JB, Benner R, Prens EP.
    J Immunol; 1997 Mar 15; 158(6):2955-63. PubMed ID: 9058835
    [Abstract] [Full Text] [Related]

  • 7. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.
    Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb AB.
    Proc Natl Acad Sci U S A; 1989 Aug 15; 86(16):6367-71. PubMed ID: 2474833
    [Abstract] [Full Text] [Related]

  • 8. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis.
    Otkjaer K, Kragballe K, Funding AT, Clausen JT, Noerby PL, Steiniche T, Iversen L.
    Br J Dermatol; 2005 Nov 15; 153(5):911-8. PubMed ID: 16225599
    [Abstract] [Full Text] [Related]

  • 9. Lack of correlation between interleukin 6 and interleukin 1 levels in psoriatic lesional skin.
    Takematsu H, Tagami H.
    Tohoku J Exp Med; 1994 Mar 15; 172(3):243-52. PubMed ID: 8073436
    [Abstract] [Full Text] [Related]

  • 10. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A, Kanno H, Watabe D, Akasaka T, Sawai T.
    Arch Dermatol Res; 2008 Jan 15; 300(1):37-45. PubMed ID: 17960400
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
    Piskin G, Sylva-Steenland RM, Bos JD, Teunissen MB.
    J Immunol; 2006 Feb 01; 176(3):1908-15. PubMed ID: 16424222
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts.
    Konstantinova NV, Duong DM, Remenyik E, Hazarika P, Chuang A, Duvic M.
    J Invest Dermatol; 1996 Oct 01; 107(4):615-21. PubMed ID: 8823370
    [Abstract] [Full Text] [Related]

  • 13. Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2.
    Johansen C, Funding AT, Otkjaer K, Kragballe K, Jensen UB, Madsen M, Binderup L, Skak-Nielsen T, Fjording MS, Iversen L.
    J Immunol; 2006 Feb 01; 176(3):1431-8. PubMed ID: 16424170
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
    Hammerberg C, Arend WP, Fisher GJ, Chan LS, Berger AE, Haskill JS, Voorhees JJ, Cooper KD.
    J Clin Invest; 1992 Aug 01; 90(2):571-83. PubMed ID: 1386612
    [Abstract] [Full Text] [Related]

  • 15. Detection of interleukin-1 receptors in human epidermis. Induction of the type II receptor after organ culture and in psoriasis.
    Groves RW, Sherman L, Mizutani H, Dower SK, Kupper TS.
    Am J Pathol; 1994 Nov 01; 145(5):1048-56. PubMed ID: 7977638
    [Abstract] [Full Text] [Related]

  • 16. Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol.
    Rømer J, Hasselager E, Nørby PL, Steiniche T, Thorn Clausen J, Kragballe K.
    J Invest Dermatol; 2003 Dec 01; 121(6):1306-11. PubMed ID: 14675174
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-1: a key inflammatory mediator in psoriasis?
    Mee JB, Cork MJ, di Giovine FS, Duff GW, Groves RW.
    Cytokine; 2006 Jan 21; 33(2):72-8. PubMed ID: 16460958
    [Abstract] [Full Text] [Related]

  • 18. Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines.
    Funding AT, Johansen C, Kragballe K, Otkjaer K, Jensen UB, Madsen MW, Fjording MS, Finnemann J, Skak-Nielsen T, Paludan SR, Iversen L.
    J Invest Dermatol; 2006 Aug 21; 126(8):1784-91. PubMed ID: 16543895
    [Abstract] [Full Text] [Related]

  • 19. IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta.
    Cooper KD, Hammerberg C, Baadsgaard O, Elder JT, Chan LS, Sauder DN, Voorhees JJ, Fisher G.
    J Immunol; 1990 Jun 15; 144(12):4593-603. PubMed ID: 2191038
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro.
    Schulz BS, Michel G, Wagner S, Süss R, Beetz A, Peter RU, Kemény L, Ruzicka T.
    J Immunol; 1993 Oct 15; 151(8):4399-406. PubMed ID: 7691948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.